Director, Molecular Imaging at GSK to speak at 3rd Imaging in Drug Development conference March 2008
Released on: January 7, 2008, 10:46 am
Press Release Author: GTCBIO
Industry: Pharmaceuticals
Press Release Summary: MONROVIA, CA - Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio's 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego.
Press Release Body: Director, Molecular Imaging at GSK to speak at 3rd Imaging in Drug Development conference March 2008
FOR IMMEDIATE RELEASE December 20, 2007
MONROVIA, CA - Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio's 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego.
Dr. Sarkar will present on molecular imaging approaches to in vivo pharmacokinetic and pharmacodynamic studies: a pharmaceutical prospective.
A major challenge facing the pharmaceutical industry today is the high attrition of drugs. This is, in large part, due to efficacies that are lower than expected from pre-clinical and clinical studies, and from side effects that are higher than expected in these studies. It is critical, therefore, to measure PK/PD relationship of compounds from target and pathways specific measurements in vivo early in preclinical drug discovery and development to increase the predictive values of preclinical studies. Multi-modal molecular imaging technologies promise to be a powerful approach towards addressing these issues.
Towards this end, Dr. Sarkar's talk will emphasize the development of multi-modal imaging methodologies to measure efficacy, safety, mechanism of action and distribution of compounds in live animals and in real time across many therapeutic areas.
Potential translation of these methodologies to clinical studies will also be discussed.
The 3rd Imaging in Pre-clinical & Clinical Drug Development conference features presentations on novel imaging methods and technology, imaging in drug development and therapy, imaging applications in CNS, imaging applications in oncology and imaging applications in the cardiovascular system. For more information, visit www.gtcbio.com.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
2022
